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Abstract
Purpose: Opioid overdose death rates rose 36% from 2015 to 2016 in Missouri, indicating a 
worsening of the opioid overdose epidemic. To better understand urban and rural differences in 
nonfatal opioid overdoses treated in Missouri emergency departments, this paper analyzed hospital 
billing data from emergency departments due to opioid overdose from 2012 to 2016.
Methods: Emergency department records meeting the opioid overdose case definition were 
aggregated into 6 progressively rural groups using the National Center for Health Statistics 
(NCHS) urban-rural county classification from 2013. These data were analyzed to determine 
significant trends amongst and between the geographic groups.
Findings: Generally, the magnitude of opioid overdose morbidity decreased as levels of rurality 
increased, using annual percentage change as the metric of change. Over the study period, 
Missouri’s most urban counties had significantly higher rates of opioid overdose and saw larger 
percentage increases in rates compared to more rural areas. Statewide, all rural-urban 
classifications experienced increases in heroin overdose morbidity; however, there was extreme 
variation in the trajectory of those increases. Heroin overdose rates were much higher in urban 
areas than rural areas. Conversely, rural and urban areas saw relatively similar patterns for non-
heroin opioid overdoses, though overall magnitude of these increases was more modest across all 
geographic groups.
Conclusions: The results from this analysis can help inform prioritization of strategies and 
resources to implement activities addressing the opioid overdose epidemic. Using a rich hospital 
discharge database could allow for further analysis of subpopulations to enhance personalization 
and customization of care.
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The opioid overdose epidemic has become an increasingly large public health crisis in the 
United States; however, this problem did not emerge overnight. This epidemic can be 
described as 3 overlapping waves, starting in the 1990s with an increase in deaths related to 
natural and semisynthetic opioids (including the most commonly prescribed opioid pain 
relievers such as oxycodone and hydrocodone). In the last 15 years, over 188,000 people 
died from overdoses involving opioids in the United States.1 The second wave of the 
epidemic began in 2010 with increases in the number of heroin deaths. For 2016, the heroin-
related death rate increased substantially (over 4-fold) since 2010 and over 15,000 
Americans died from heroin.2,3 Mortality involving heroin overdose now exceeds natural 
and semisynthetic opioids (eg, hydrocodone, oxycodone) and is lagging just behind 
synthetic opioids other than methadone as the leading cause of opioid-related death.3 
Beginning in 2013, the third wave includes the large and drastic increases in deaths related 
to synthetic opioids other than methadone, which is likely driven by illicitly manufactured 
fentanyl and fentanyl analogs. Fentanyl is a synthetic and short-acting opioid analgesic and 
is 50–100 times more potent than morphine. The death rate for synthetic opioids other than 
methadone has now surpassed all other opioids in the last 5 years, and in 2016 over 19,000 
Americans died from synthetic opioids.4 In 2016, more than two-thirds of drug overdose 
deaths nationwide involved an opioid. Opioid deaths in 2016, including both illicit and 
prescription opioids, increased by more than 5-fold compared to 1999.4 The most recent 
estimates indicate that opioid-involved deaths increased 28% from 2015 to 2016.3 During 
this time period there was a 100% increase in deaths due to synthetic opioids other than 
methadone (eg, illicitly manufactured fentanyl).3
Though data on opioid overdose deaths provides the mortality burden of this epidemic, 
emergency department (ED) data are another source that can be used to create a more 
informed narrative on the opioid crisis. ED data have the additional benefit of a reduced time 
lag in comparison to receiving finalized death certificates, which can better assist states in 
not only identifying opioid-involved overdose, but also in responding more effectively by 
quickly providing resources to communities in need. Most recent estimates from 16 states 
across the United States indicate a 30% increase in opioid overdose visits to EDs from July 
2016 through September 2017.5 Vivolo-Kantor et al5 also found increases for most states in 
the United States, with some states showing larger increases than other states. In addition, 
disparities between levels of urbanization were examined. Though all urbanization levels 
saw large increases, large fringe metropolitan areas witnessed the largest increases (54%), 
indicating a potential worsening of the epidemic in certain types of geographic areas.5 
Tracking opioid overdose deaths by geographic areas and urbanization is critical to inform 
and target interventions.
To better track the trends of this epidemic in states across the United States, the Centers for 
Disease Control and Prevention (CDC) initiated the Enhanced State Opioid Overdose 
Surveillance (ESOOS) program in 2016, which now funds 32 states and the District of 
Columbia to report on nonfatal and fatal drug overdoses in a timelier manner through 
September 2019. Funded state health departments are required to provide quarterly reports 
on 2 of the 3 following indicators: suspected drug, opioid, or heroin overdoses treated in the 
EDs. Stratifications by sex, age group, and county are also reported. Additionally, biannual 
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opioid-involved mortality data from medical examiners/coroners are reported, which 
includes toxicology reports and death scene investigations, allowing more data on the 
specific drugs involved in fatal overdose. The purpose of the ESOOS program is to capture 
these data so that response efforts can effectively target areas most in need of intervention.
This study uses data analyzed as part of ESOOS to measure the disparities in nonfatal opioid 
overdoses (including heroin and non-heroin opioid overdoses) among urban and rural areas 
in the state of Missouri. By some metrics in Missouri, opioid-involved deaths have seen 
larger increases than national averages. Missouri has consistently been approximately 15% 
higher than the United States average for opioid overdose deaths over the last decade.1 Over 
time, deaths involving opioids have increased drastically in Missouri and, in 2016, the state’s 
908 opioid overdose deaths were more than 8 times the total in 2001. From 2015 to 2016 
alone, Missouri saw a 36% increase in all opioid-involved deaths, largely driven by a 26% 
increase in deaths involving heroin and a 152% increase in deaths involving synthetic 
opioids other than methadone.3 In a recent report from CDC,5 Missouri witnessed a 21% 
increase from July 2016 through September 2017 in nonfatal opioid overdose visits seen in 
EDs. However, the scale and scope of opioid-related morbidity may vary widely across 
Missouri’s 115 counties, and grouping these counties by rurality allows for exploration of 
differences in spatial patterns for various opioid overdose subcategories. This study further 
examines these urban and rural differences using the most up-to-date hospital billing data 
from EDs for 2012–2016.
Methods
Study Population
Morbidity data utilized in this analysis are from the Patient Abstract System (PAS) 
maintained by the Missouri Department of Health and Senior Services (MDHSS). By state 
statute, all Missouri licensed hospitals are required to submit inpatient, emergency room, 
and select outpatient discharges to MDHSS, resulting in an annual file that includes well 
over 3 million records. Among other variables, these patient records contain basic 
demographic information such as age, race, sex, and county of residence, as well as 
information about the purpose of the visit (eg, diagnosis codes). The study population for 
this analysis included all ED visits in the PAS from January 1, 2012, through December 31, 
2016, for Missouri state residents ages 11 years and older. Rates per 10,000 residents were 
generated using US Census Bureau estimates for the resident county population ages 11 and 
older and were not age-adjusted.
Opioid Overdose Case Definition
The definitions for opioid, heroin-specific and non-heroin opioid overdose were developed 
in collaboration with the CDC through the ESOOS cooperative agreement. Opioid overdose 
cases for Missouri residents were identified and further classified into 1 of the 2 mutually 
exclusive subtypes described below based on the International Classification of Diseases, 
Ninth Revision, Clinical Modification (ICD-9-CM) and International Classification of 
Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) discharge diagnosis codes 
assigned by hospital staff. The first 5 of 23 discharge diagnosis code fields were used to 
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categorize opioid overdose discharges with either ICD-9-CM (covering 2012 through 
September 2015) or ICD-10-CM codes (covering October 2015 through the remainder of 
2016). The first category, all opioid overdoses, included codes for poisoning by opium 
(T40.0X1A or T40.0X4A), other opioids (T40.2X1A or T40.2X4A), methadone (T40.3X1A 
or T40.3X4A), synthetic narcotics (T40.4X1A or T40.4X4A), unspecified narcotics 
(T40.601A or T40.604A), other narcotics (T40.691A or T40.694A), or heroin (T40.1X1A or 
T40.1X4A). The second category, heroin overdoses, included only codes T40.1X1A or 
T40.1X4A. The final category, non-heroin opioid overdoses, included all opioid codes 
except T40.1X1A or T40.1X4A. Visits that included an opioid code (eg, T40.691A) and a 
heroin code (T40.1X1A) were coded as heroin overdose. Hospitalization billing data from 
2016 used in this analysis are considered provisional as the annual file is not finalized until 
all out-of-state records are received, generally in mid-summer. Our case definition includes 
codes for unintentional and undetermined drug poisoning intent using only the initial 
encounter to remove potential duplicate visits. A record containing both subtypes of opioid 
overdose was categorized as a heroin overdose.
Analytic Plan
ED records for the study period of 2012–2016, identified in the PAS as meeting the opioid 
overdose case definition, were aggregated into categories based on the patient’s county of 
residence using the National Center for Health Statistics (NCHS) urban-rural county 
classification from 2013.6 This methodology uses metropolitan and micropolitan statistical 
area designations, as well as overall Metropolitan Statistical Area (MSA) population size 
and principal city population estimates, to categorize Missouri counties into 6 progressively 
rural groups (see Figure 1). The most urban designation, Large Central Metro (LCM), 
included only 2 counties in Missouri, which contain the core cities of Kansas City and St. 
Louis. A total of 14 counties met the criteria for the Large Fringe Metro (LFM), and these 
counties surround the 2 LCM counties in the state. The Medium Metro (MM) classification 
included the third largest city in the state, Springfield, as well as several counties that 
surround it. In addition, 1 county in Missouri that is a part of the Northwest Arkansas metro 
falls in this classification. Progressively smaller, less dense urban areas are categorized as 
Small Metro (SM), which includes counties associated with or near Joplin, Columbia, 
Jefferson City, St Joseph, and Cape Girardeau. Finally, the Micropolitan (MCO) class 
includes counties that contain cities with a population between 10,000 and 50,000 persons. 
The majority of Missouri’s counties (59) fell into the most rural classification of Noncore 
(NC). The LFM contains the highest percentage of Missouri’s population with 38%. By 
comparison, the NC contains 14% and the smallest group by population is the MM with 8% 
(Table 1).
These data were then analyzed across time, space, and specific type of opioid overdose 
diagnosis. Ninety-five percent confidence intervals were used as the primary significance 
test to determine meaningful differences between data points for county groupings, specific 
years within the study period, or the study period as a whole. Frequencies in the numerator 
determined whether the Poisson (when numerator frequencies exceeded 500) or inverse 
gamma methodology was used to develop confidence intervals. All database management 
and some statistical testing were completed using SAS 9.4 (SAS Institute Inc., Cary, NC). 
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Further testing through regression analysis was conducted using the National Cancer 
Institute’s Joinpoint Regression Program version 4.5.0.1 to assess linear trends and calculate 
annual percentage change (APC).
Results
All Opioid Overdose
The rate of all opioid overdose-related ED discharges increased significantly, by more than 
100% (3.08 to 6.33) from 2012 to 2016, with an APC of 22.0% (Table 2). This doubling of 
ED discharge rates reflects a steady rise from 2012 to 2014, followed by a surge of cases 
from 2015 to 2016.
Opioid overdoses presenting to EDs are increasing statewide; however, the increases for the 
2 most urban categories, LCM and LFM, are notable. These categories have 2016 rates that 
are 2–3 times higher than the MM, SMC, MCO, and NC groups (Table 2 and Figure 2). 
Additionally, the rate increases were much steeper than the gradual gains seen in the 4 other 
more rural areas. The APCs for the 2 most urban areas of LCM and LFM (25.0% and 
26.2%, respectively) were significant. The greatest increases occurred between 2014 and 
2016, where rates doubled from 4.99 (LCM) to 9.92 and 4.38 to 8.73 (LFM). Furthermore, 
these 2 groups also account for nearly 75% of all fatal opioid overdoses statewide during the 
study period.
Three of the middle density categories (MM, SM, and MCO) each experienced 2016 opioid 
overdose discharge rates that were more than 1.5 times higher than their rates in 2012, 
though the overall linear trend for the MM counties did not reach statistical significance.
The most rural areas in Missouri, NC counties, saw the smallest increases in overall rates of 
opioid overdose-related discharges. The discharge rate for these counties was highest in 
2015, but this rate was half that of the rates in the most urban categories of LCM and LFM. 
Overall, the NC rate for 2016 was the second lowest of the 6 categories (only SM was 
lower). However, NC counties experience the third highest absolute number of overdoses 
(roughly 9% of the Missouri total) for the study period.
Heroin Overdose
Heroin overdose ED discharge counts increased more than 190% statewide during the study 
period—this subtype of opioid overdose has been the greatest driver of change in Missouri. 
Though frequencies are low in some NCHS groups, heroin overdose ED discharges and 
associated rates had increases from 2012 to 2016 for all urbanization levels, and all trends 
were statistically significant (using APC), except the MM area (Table 3 and Figure 3). 
Across the entire study period, residents of the most urban region of Missouri (LCM) had 
over a 650% increased risk (risk ratio 7.62) of being discharged from the ED for a heroin-
related overdose than their most rural (NC) counterparts (LCM rate: 4.04, NC rate: 0.53). 
Missouri’s 2 most urban groupings, LCM and LFM, account for almost 90% of the fatal 
heroin overdoses in the state during this study period.
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While regions other than LCM and LFM have lower overall rates, these more rural areas 
experienced the largest percentage increases in the state over the study period, heralding the 
spread of heroin overdose outward from the most urban regions in more recent years. In 
2012, 92% of all heroin-related overdose discharges occurred among residents living in the 2 
most urban classifications (LCM and LFM); however, by 2016 that number had dropped to 
87%, with the least dense population areas seeing increased burden (increases from 5% to 
8% of the total burden in MCO and NC areas during the study period). While NC areas had 
relatively lower heroin overdose rates compared to other urbanization levels in 2016, they 
were more than 5 times higher than the 2012 rates.
The MM region, the smallest in terms of population of the 6 groupings, experienced both 
small overall counts and large increases of heroin overdose. Less than 3% of heroin cases in 
Missouri during this time period were attributed to residents in MM counties. While the total 
percent change between 2012 and 2016 for MM was over 500%, the overall linear trend did 
not reach significance. The greatest percentage increase during the study period for this area 
occurred in 2013–2014, where heroin-specific discharges jumped from 8 cases to 26.
Non-heroin Opioid Overdose
Results for non-heroin opioid overdoses reflect a different pattern. Statewide non-heroin 
opioid overdose discharges happen less frequently than heroin-related discharges, and rates 
have remained considerably more stable than the heroin trends over the same time period. 
Missourians experienced a 29% increase in non-heroin opioid overdose discharges during 
the study period, compared to the 190% increase for heroin-specific discharges. Though not 
statistically significant, the portion of time between 2014 and 2016 shows steep increases for 
the LCM region, with APC fluctuations from −14.1% (2012–2014) to +31.8% (2014–2016).
Statewide linear trends over time did not show significant APC changes, though the second 
most urban group of counties, LFM, saw a significant upward trend in non-heroin opioid 
overdose ED discharges with an APC of 17.6% (Table 4) during the study period. This 
cohort comprised 27% of statewide non-heroin opioid overdoses in 2012, which increased to 
nearly 40% by 2016.
The most rural grouping, NC, saw a significant decrease in non-heroin opioid overdose ED 
discharges. Rates fell from 2.16 to 1.75 over 5 years—a decrease of nearly 20%. This 
contrasts with a significant increase in heroin-specific ED discharges for the NC class during 
the same time, though it should be noted that the non-heroin opioid overdose rates continue 
to be higher than heroin-specific rates for NC counties. Early in the study period (2012) NC 
rates were commensurate with LCM rates; however, trends have since diverged, specifically 
in 2016 when the LCM rate was significantly higher than the rate for NC counties. Between 
2013 and 2014, the NC rate was significantly higher than the LCM rate. However, by 2015, 
the rates for these 2 classes were nearly identical, and in 2016, the LCM rate was much 
higher than the NC rate (Figure 4).
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Discussion
To better understand urban and rural differences in nonfatal opioid overdoses treated in 
Missouri EDs, this paper analyzed hospital billing data from ED discharges due to opioid 
overdose, including heroin, from 2012 to 2016. Our findings indicate that, overall, Missouri 
saw increases in nonfatal opioid (106%), heroin (185%), and non-heroin opioid (27%) 
overdose rates from 2012 to 2016. However, we identified disparities in rural and urban 
areas throughout the state whether or not the overdose involved heroin. Missouri’s more 
urban counties (LCM and LFM) had significantly higher rates of overdose for the entire 
study period and moreover, those urban counties have seen larger percentage increases in 
rates compared to their more rural counterparts. The differences between rural and urban 
areas in Missouri warrant additional exploration.
Mortality data analyzed by Mack et al7 found that opioid overdose death rates in rural 
counties across the United States increased from 2010 to 2015, but in 2016, rates seem to be 
more stable and the largest increases are now occurring in more urban areas. The dramatic 
increases in mortality seen nationally in urban areas are consistent with increases seen in the 
more urban areas in Missouri—especially for heroin overdoses. However, this trend in all 
opioid mortality is inconsistent with our findings that in the most rural areas of Missouri 
(NC counties), non-heroin opioid discharges were highest in 2013 and have decreased 
significantly since that time. Heroin-specific overdose discharge rates for this grouping have 
increased significantly, as well, though frequencies remain low compared to more urban 
groupings. On the other hand, the largest increases in opioid overdose death rates across the 
United States are now occurring in more urban areas.3 Our data also support these findings, 
especially for heroin overdose where more urban areas witnessed large and significant 
percentage increases from 2012 to 2016.
While overdose mortality was not the focus of this study, Missouri resident opioid overdose 
deaths were examined using the same NCHS geographic categories and time period. 
Mortality data findings closely resembled emergency room discharge rates due to opioid 
overdose. LCM and LFM areas experienced the highest rates of opioid overdose deaths, 
having statistically significantly higher rates compared to the 4 more rural groupings during 
the entire study period. All geographic areas saw increases in heroin overdose death rates 
over the 5-year time period, while only LCM and LFM areas saw large percentage increases 
in non-heroin overdose deaths. In 2016, Missouri experienced an over 30% increase in 
opioid overdose deaths from the previous year and a 70% increase from 2012.
The reasons behind why we are seeing these increases are not entirely clear. More in-depth 
analysis of other types of data, including drug supply data or emergency medical services 
(EMS) data, could provide some additional context. Future analyses could also overlay 
county EMS data, ED discharges, and mortality data to explore these changes. In addition, 
law enforcement drug product reports from the Drug Enforcement Agency (DEA) could 
shed light on the types and amounts of opioids introduced and seized in the community.
Another important finding is that while increases in heroin overdose are driving increases in 
opioid overdoses across all urbanization levels, increases in non-heroin opioid overdose are 
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also occurring in the more urban (LFM) locations. This may be due to the increase in 
availability and use of illicitly manufactured fentanyl (IMF) and fentanyl analogs in urban 
areas. In Missouri, evidence suggests that fentanyl analogs began infiltrating the opioid 
supply in LCM areas in 2015 and has since spread to LFM and MM areas.8–10 With the high 
potency and rapid onset of reaction in the body, it is possible that the increase in overdose 
ED visits is driven by increases in the introduction of IMF in the drug supply. This is 
particularly true in situations where a drug user unknowingly uses IMF that has been mixed 
with the substances they purchase. Using our methodology, if a patient tests positive for both 
heroin and a non-heroin substance, like IMF, that record would be coded as a heroin 
overdose. However, we are not aware of the breadth nor the specificity of toxicology testing 
in all Missouri ED facilities.
Other states have shared reports of IMF distributed in counterfeit prescription pills or sold to 
individuals using substances with or without their knowledge that the product contains 
IMF11,12; thus, it is possible that this, too, is occurring in Missouri. More recently, anecdotal 
evidence from Missouri law enforcement officials indicates that sometimes IMF is being 
sought by individuals with substance use disorder.9 In addition, IMF is now being found in 
other drug groups beyond opioids, including cocaine.9 Unfortunately, because no specific 
ICD-10-CM code exists for IMF, and without additional information from hospital staff (eg, 
free text chief complaint or nurse triage notes), we cannot be certain how much IMF is 
playing a role in increasing overdose in urban Missouri areas.
Limitations
This study is not without several limitations. Foremost, this study focuses on nonfatal 
overdoses, which have nuanced implications that differ from those associated with fatal 
overdoses. It stands, however, that in Missouri the rate of fatal opioid overdoses during the 
study period was highest for the LCM category and comparatively significantly lower for the 
NC group, which mimics the findings of this nonfatal overdose analysis. Second, our case 
definition cannot take into consideration fluctuations in coding decisions and the coding 
changes precipitated by the transition from ICD-9-CM to ICD-10-CM, which occurred 
during the final 15 months of our study. It is possible that this transition may play a role in 
the increases or decreases witnessed. Third, no specific ICD-9-CM or ICD-10-CM code 
captures fentanyl overdoses, and it is likely that fentanyl overdoses are captured with both 
heroin overdose codes and codes for other or unknown narcotic. In our current classification 
scheme, cases with both a heroin and non-heroin opioid overdose code were classified as 
heroin; however, fentanyl overdoses have different presentation and treatment modalities 
than other non-heroin opioid overdoses.8,13 Finally, several of the county groupings had low 
annual frequencies of opioid overdose-related ED discharges. During the 5-year study 
period, several of the NCHS classes, including MM, SM, and NC, have years in which there 
were less than 20 heroin-specific ED discharges. This makes rate comparisons unreliable 
and makes significant findings less likely.
Notwithstanding these limitations, this study has several strengths. The robust PAS dataset 
allows analysts to generate a fairly comprehensive understanding of an ED patient and the 
circumstances surrounding their visit and subsequent discharge. Geospatial analysis will 
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allow public health professionals and others to address the specific needs of geographically 
granular areas in developing interventions related to the opioid overdose epidemic in 
Missouri.
Implications
By examining Missouri’s opioid overdose epidemic by time, geography, and opioid subtype, 
findings from this study could better equip those responding to the crisis. These 
considerations heavily impact intervention strategies. For example, a greater understanding 
of how these factors are associated with a community could drive evidence-based 
programming and resource allocation. Furthermore, the results from this analysis can help 
inform prioritization of strategies and resources to implement activities to address the opioid 
overdose epidemic within the states. Using a rich hospital discharge database, like the 
Missouri PAS database described here, could allow for further analysis of subpopulations by 
age, sex, race, ethnicity, and other factors that could enhance the personalization and 
customization of care during this health crisis.
This analysis may have implications for public health, law enforcement, and service 
providers in Missouri and may be of interest to other Midwestern states that have similarly 
high rates of fatal and nonfatal opioid overdose. In addition to increasing rates of opioid 
overdose ED discharges statewide, rural and urban communities in Missouri face somewhat 
different challenges in addressing the epidemic. The sheer burden of the overdose crisis to 
these urban counties in Missouri cannot be understated. The most urban areas of LCM and 
LFM continue to respond to significantly high rates of heroin-specific discharges and deaths 
while contending with rising non-heroin opioid overdose discharge rates. The increase in 
non-heroin opioid overdose may be the result of the introduction of fentanyl to the opioid 
supply, either mixed into heroin or pressed into counterfeit prescription pills. The NC areas, 
which are Missouri’s most rural, continue to see higher rates of non-heroin opioid overdose 
discharges than heroin-specific discharges, but a steady increase in heroin-related discharges 
with a decrease in non-heroin opioid overdose discharges indicates a shift may be occurring.
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Figure 1. 
NCHS Map—Missouri County Classifications.
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Figure 2. 
Trends in Opioid Overdose ED Discharges From 2012 to 2016, Missouri by Urbanization.
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Figure 3. 
Trends in Heroin-Specific Overdose ED Discharges From 2012 to 2016, Missouri by Urban-
Rural County Classifications.
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Figure 4. 
Trends in Non-heroin Overdose ED Discharges From 2012 to 2016, Missouri by 
Urbanization.
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